首页> 外文期刊>Pediatric Reports >Novel use of an ultrafiltration device as an alternative method for fluid removal in critically ill pediatric patients with cardiac disease: a case series
【24h】

Novel use of an ultrafiltration device as an alternative method for fluid removal in critically ill pediatric patients with cardiac disease: a case series

机译:超滤设备作为心脏疾病重症儿科患者体液清除的替代方法的新用途:病例系列

获取原文
           

摘要

Fluid overload (FO) is a common complication for pediatric patients in the intensive care unit. When conventional therapy fails, hemodialysis or peritoneal dialysis is classically used for fluid removal. Unfortunately, these therapies are often associated with cardiovascular or respiratory instability. Ultrafiltration, using devices such as the AquadexTM system (Baxter Healthcare, Deerfield, IL, USA), is an effective tool for fluid removal in adult patients with congestive heart failure. As compared to hemodialysis, ultrafiltration can be performed using smaller catheters, and the extracorporeal volume and minimal blood flow rates are lower. In addition, there is no associated abdominal distension as is seen in peritoneal dialysis. Consequently, ultrafiltration may be better tolerated in critically ill pediatric patients. We present three cases of challenging pediatric patients with FO in the setting of congenital heart disease in whom ultrafiltration using the AquadexTM system was successfully utilized for fluid removal while cardiorespiratory stability was maintained.
机译:液体超负荷(FO)是重症监护室中小儿患者的常见并发症。当常规疗法失败时,血液透析或腹膜透析通常用于清除液体。不幸的是,这些疗法通常与心血管或呼吸系统不稳定有关。使用AquadexTM系统(美国伊利诺伊州迪尔菲尔德的Baxter Healthcare公司)等设备进行的超滤是一种用于成人充血性心力衰竭患者清除液体的有效工具。与血液透析相比,可以使用较小的导管进行超滤,并且体外体积和最小血液流速较低。另外,如腹膜透析所见,没有相关的腹胀。因此,危重儿科患者可更好地耐受超滤。我们介绍了三例先天性心脏病患者的FO挑战性儿科患者,其中使用AquadexTM系统的超滤成功地去除了液体,同时保持了心肺稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号